Feedback
Settings

Settings

Goto Application

1. WO1990007122 - DIAGNOSTIC ASSAY FOR THE DETECTION OF PREECLAMPSIA

PermaLink
Publication Number WO/1990/007122
Publication Date 28.06.1990
International Application No. PCT/US1989/005560
International Filing Date 13.12.1989
Chapter 2 Demand Filed 18.06.1990
IPC
C07K 14/47 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
G01N 33/50 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N 33/68 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
CPC
C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
G01N 2800/368
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
36Gynecology or obstetrics
368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
G01N 33/5091
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
5005involving human or animal cells
5091for testing the pathological state of an organism
G01N 33/6893
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
6893related to diseases not provided for elsewhere
Applicants
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US]/[US] (AllExceptUS)
  • ROBERTS, James, M. [US]/[US] (UsOnly)
  • TAYLOR, Robert, N. [US]/[US] (UsOnly)
Inventors
  • ROBERTS, James, M.
  • TAYLOR, Robert, N.
Agents
  • WEBER, Kenneth, A.
Priority Data
284,21214.12.1988US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) DIAGNOSTIC ASSAY FOR THE DETECTION OF PREECLAMPSIA
(FR) EXAMEN DIAGNOSTIQUE SERVANT A LA DETECTION DE LA PRE-ECLAMPSIE
Abstract
(EN) This invention relates to the diagnosis of preeclampsia using an assay to measure a mitogenic factor in blood. Preeclampsia is a serious problem in pregnant women. It is an idiopathic life threatening hypertensive condition. The condition of preeclamptic women can often deteriorate to a point where serious injury will occur to either the mother, child or both. Preeclampsia is a leading cause of death both maternal and infant.
(FR) La présente invention se rapporte au diagnostic de la pré-éclampsie par examen destiné à mesurer un facteur mitogénique dans le sang. La pré-éclampsie est un problème grave chez les femmes enceintes. Elle se manifeste par un état d'hypertension idiopathique pouvant entraîner la mort. L'état d'une femme souffrant de pré-éclampsie peut se détériorer au point d'entraîner des lésions graves aussi bien chez la mère que chez l'enfant. La pré-éclampsie est une cause première de mortalité maternelle et infantile.
Related patent documents
EP0440750
JP1992505804
US5238819
Latest bibliographic data on file with the International Bureau
# -